Olmesartan-induced enteropathy treated with budesonide
| Journal | Volume 82 - 2019 |
| Issue | Fasc.2 - Case reports |
| Author(s) | S. Kempenaers, J. Bogaert, M. De Maeyer, P. Van Hauthem, M. Ramael, P. Schoeters |
| Full article |
 VIEW FREE PDF |
| (1) Faculty of Medicine, University of Leuven, 3000 Leuven, Belgium ; (2) Department of Gastroenterology, AZ Herentals, 2200 Herentals, Belgium ; (3) Department of Pathology, AZ Herentals, 2200 Herentals, Belgium ; (4) Department of Cytology and Histology, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium. |
|
Olmesartan, an angiotensin receptor blocker, is a widely spread antihypertensive drug. Seronegative villous atrophy of the small intestine due to olmesartan use was first described in 2012. We present a new case of olmesartan-induced enteropathy and compare it to recent literature. This case might suggest a use of budesonide for treatment. (Acta gastroenterol. belg., 2019, 82, 319-321). |
|
© Acta Gastro-Enterologica Belgica. PMID 31314195 |
